Hormone Therapy News

In early postmenopausal women, the incidence of type 2 diabetes can be reduced by the estradiol-mediated effects on insulin action, according to recent study findings published in The Journal of Clinical Endocrinology & Metabolism.

Reducing the dosage of progesterone in postmenopausal women on low-dose transdermal hormone therapies provided safe and effective relief of menopausal symptoms, according to recent study findings presented at The North American Menopause Society Annual Meeting.

Health effects of menopausal hormone therapy, especially heart disease, differ among women based on when they started treatment, according to recent study findings presented at The North American Menopause Society Annual Meeting.

Menopausal women with genitourinary symptoms are more likely to use vaginal estrogen treatment and to stick with treatment longer when it comes in tablet form compared with cream, according to recent study findings presented at The North American Menopause Society Annual Meeting.

The withdrawal of postmenopausal hormone therapy can raise the risk for cardiovascular mortality and stroke, particularly in the first year after discontinuation and in recently menopausal women, according to research in The Journal of Clinical Endocrinology & Metabolism.

Postmenopausal women with osteopenia randomly assigned nightly melatonin for 12 months saw reductions in both fat mass and body fat percentage when compared with women assigned placebo, according to research in Clinical Endocrinology.

The American Association of Clinical Endocrinologists recently issued a position statement, published in Endocrine Practice, citing lack of evidence linking testosterone replacement therapy with cardiovascular events.

Contraceptive options for women have been readily available since the 1960s, but the options for men are few — condoms, vasectomy for permanent fertility control and withdrawal for versatile fertility control.

Men with type 2 diabetes and low testosterone treated with 12 months of testosterone therapy saw improvements in lipid profiles, glycemic control and metabolic profiles in addition to increased testosterone levels, according to study findings presented at the 51st European Association for the Study of the Diabetes Annual Meeting.

Middle-aged and older men with hypogonadism receiving testosterone therapy lost weight and improved their HbA1c, glucose level, blood pressure and lipid profile, according to research in Clinical Endocrinology.